Hanmi to register patent for a modified G-CSF in Europe.
Published: 2005-08-24 06:57:00
Updated: 2005-08-24 06:57:00
Hanmi announced on Aug. 19 that the patent for the production and process of "a modified stimulant (G-CSF) of human granulocyte colony", a protein for the treatment of leukocytopenia accompanied by the chemotherapy was completed in Europe.
Hanmi said that the candidated compound called "HM-104...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
